Serum Institute, Bharat Biotech to Begin Trial of Intranasal Covid Vaccine Soon
Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal Covid-19 vaccines in the coming months once they receive regulatory approval, Union health minister Harsh Vardhan said on Sunday.